Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) where stereochemistry plays a critical role in biological activity. Its structure supports the creation of enantioselective intermediates in asymmetric synthesis. Commonly employed in the preparation of protease inhibitors and other bioactive molecules. Also utilized in research settings for the design of novel catalysts and ligands in enantioselective reactions.